Interestingly, multivariate analysis revealed that eIF4E intensity in tumours was an independent prognosticator for relapse‐free survival (RFS) and was significantly associated with clinic ‐pathologic features (serum alpha‐fetoprotein level, gamma glutamyl transferase, vascular invasion of HCC) (Table 1). This evidence concerns the gene EIF4E and hepatocellular carcinoma.